Keyphrases
Acute Hepatitis
12%
Amino Acid Substitution
9%
Anti-HBe
12%
Antiviral Treatment
10%
Basal Core Promoter mutation
10%
Chronic Hepatitis
10%
Chronic Hepatitis B
19%
Chronic Hepatitis B Virus Infection
44%
Chronic Liver Disease
12%
Core Promoter
11%
Fulminant Hepatitis
8%
GB Virus C (GBV-C)
11%
HBV DNA
12%
Hepatitis
18%
Hepatitis A Virus
13%
Hepatitis B
17%
Hepatitis B Carrier
12%
Hepatitis B e Antigen (HBeAg)
44%
Hepatitis B Surface Antigen (HBsAg)
42%
Hepatitis B Virus
77%
Hepatitis B Virus DNA
40%
Hepatitis B Virus Infection
16%
Hepatitis B Virus Replication
15%
Hepatitis C Virus
47%
Hepatitis C Virus Infection
10%
Hepatitis delta Virus
17%
Hepatitis G Virus
31%
Hepatitis Virus
9%
Hepatocellular Carcinoma
15%
Hepatocytes
10%
Hypervariable Region
9%
Immunization
8%
Interferon Therapy
13%
Interferon-α (IFN-α)
54%
Internal Ribosome Entry Site
8%
Liver
15%
Liver Biopsy
8%
Liver Disease
23%
Lymphoblastoid
16%
Precore
20%
Seroconversion
9%
Tamarin
13%
Thrice Weekly
8%
Viral Hepatitis
8%
Viral Replication
13%
Viremia
12%
Virus
41%
Virus Infection
14%
Virus Replication
8%
Woodchuck
13%
Immunology and Microbiology
Amino Acid Substitution
8%
Blood Product
5%
Callitrichinae
14%
Chlamydia Trachomatis
6%
Cladistics
8%
Coinfection
6%
DNA Virus
22%
Epitope
9%
HBsAg
32%
HBV DNA
5%
Hepatitis
10%
Hepatitis A Virus
13%
Hepatitis B
68%
Hepatitis B Antigen
32%
Hepatitis B Virus
100%
Hepatitis B(e) Antibody
6%
Hepatitis B(e) Antigen
35%
Hepatitis C
18%
Hepatitis C Virus
46%
Hepatitis Delta Virus
18%
Hepatitis G Virus
29%
Hepatitis Virus
13%
Human Immunodeficiency Virus
5%
Hypervariable Region
7%
Immunology
21%
interferon
26%
Interferon Alfa
7%
Internal Ribosome Entry Site
9%
Lymphoblast Interferon
7%
Membrane Antigen
7%
Monoclonal Antibody
6%
Pegivirus B
9%
Phylogeny
7%
Polymerase Chain Reaction
5%
Prevalence
16%
Promoter Region
15%
Quasispecies
8%
RNA Virus
8%
Saguinus
5%
Seroconversion
9%
Superinfection
6%
Vaccinia Virus
6%
Viral Disease
12%
Viral Replication
29%
Viremia
15%
Virus Carrier
10%
Virus Identification
5%
Virus Nucleocapsid
5%
Wild Type
5%
Woodchuck
12%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha Interferon
6%
Antivirus Agent
13%
Chronic Hepatitis
5%
Chronic Hepatitis B
50%
Chronic Liver Disease
6%
Disease
9%
Haemophilia A
7%
Hepatitis A Virus
5%
Hepatitis B
20%
Hepatitis B Antigen
18%
Hepatitis B Virus
70%
Hepatitis B(e) Antibody
5%
Hepatitis B(e) Antigen
26%
Hepatitis C
7%
Hepatitis C Virus
21%
Hepatitis G Virus
20%
Infection
19%
Interferon
22%
Lamivudine
6%
Liver Cell Carcinoma
12%
Liver Cirrhosis
9%
Liver Disease
18%
Lymphoblast Interferon
8%
Prevalence
8%
Randomized Controlled Trial
5%
Viremia
6%
Virus Antibody
5%
Virus Carrier
8%
Virus DNA
15%
Virus Hepatitis
10%
Virus RNA
5%